# A Study by ChromaDex to Assess the Effects of TRU NIAGEN on Cognitive Function, Mood and Sleep in Older Adults

> **NCT03562468** · NA · COMPLETED · sponsor: **ChromaDex, Inc.** · enrollment: 40 (actual)

## Conditions studied

- Cognitive Function
- Mood
- Sleep

## Interventions

- **DIETARY_SUPPLEMENT:** 300 mg/day of TRU NIAGEN (nicotinamide riboside)
- **DIETARY_SUPPLEMENT:** 1000 mg/day of TRU NIAGEN (nicotinamide riboside)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03562468
- **Lead sponsor:** ChromaDex, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-13
- **Primary completion:** 2019-04-26
- **Final completion:** 2019-04-26
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03562468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03562468, "A Study by ChromaDex to Assess the Effects of TRU NIAGEN on Cognitive Function, Mood and Sleep in Older Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03562468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*